Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumour”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02897765
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Who this might be right for
Urinary Bladder CancerBladder TumorsTransitional Cell Carcinoma of the Bladder+5 more
BioNTech US Inc. 34
Early research (Phase 1)Looking for participantsNCT07247110
What this trial is testing

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 250
Not applicableLooking for participantsNCT05053113
What this trial is testing

Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women

Who this might be right for
Obesity-Related Malignant Neoplasm
M.D. Anderson Cancer Center 500
Not applicableLooking for participantsNCT04501705
What this trial is testing

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults

Who this might be right for
Recurrent Atypical/malignant Meningioma
Beijing Sanbo Brain Hospital 29
Not applicableLooking for participantsNCT06814431
What this trial is testing

Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene

Who this might be right for
Idiopathic Parkinson's Disease (PD)
Azienda USL Reggio Emilia - IRCCS 3,000
Early research (Phase 1)Study completedNCT02555007
What this trial is testing

Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)Malignant Pleural Mesothelioma (MPM)
Assistance Publique Hopitaux De Marseille 30
Not applicableStudy completedNCT03824977
What this trial is testing

Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery

Who this might be right for
Lung Neoplasm MalignantResectable Lung Non-Small Cell Carcinoma
University Hospital, Rouen 122
Not applicableLooking for participantsNCT04067167
What this trial is testing

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases

Who this might be right for
CancerCancer CachexiaInflammation+1 more
University of Erlangen-Nürnberg Medical School 100
Testing effectiveness (Phase 2)UnknownNCT02759536
What this trial is testing

In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma

Who this might be right for
MelanomaBoron Neutron Capture Therapy
The Third Xiangya Hospital of Central South University 30
Not applicableLooking for participantsNCT06277531
What this trial is testing

Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)

Who this might be right for
Biliary StrictureBile Duct CancerPancreas Cancer
Peking University Third Hospital 99
Early research (Phase 1)Looking for participantsNCT07563829
What this trial is testing

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 81
Very early researchUnknownNCT03649529
What this trial is testing

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Who this might be right for
Malignant Melanoma
Timmune Biotech Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT00351039
What this trial is testing

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07594028
What this trial is testing

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours

Who this might be right for
Advanced Malignant Solid Tumor
Sinocelltech Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT04260529
What this trial is testing

CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations

Who this might be right for
Advanced Solid Tumor Malignancy
Cytovation AS 60
Not applicableNot Yet RecruitingNCT06954753
What this trial is testing

Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence

Who this might be right for
Pancreatic CancerPancreatic Cystic Lesions
Centre Hospitalier Universitaire de Nice 250
Large-scale testing (Phase 3)Study completedNCT00002995
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 483
Not applicableUnknownNCT03150992
What this trial is testing

EDMONd - Elemental Diet in Bowel Obstruction

Who this might be right for
Ovarian CancerOvarian NeoplasmsOvarian Disease+6 more
Royal Surrey County Hospital NHS Foundation Trust 34
Testing effectiveness (Phase 2)Ended earlyNCT01083537
What this trial is testing

Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

Who this might be right for
Ovarian CancerPeritoneal CancerFallopian Tube Cancer+1 more
University Health Network, Toronto 1
Testing effectiveness (Phase 2)Study completedNCT00831545
What this trial is testing

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Who this might be right for
Metastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more
Merck Sharp & Dohme LLC 162
Next Page